Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus

Paul J W H Kappelle, Josefin Ahnström, Bert D Dikkeschei, Rindert de Vries, Wim J Sluiter, Bruce H R Wolffenbuttel, Arie van Tol, Lars Bo Nielsen, Björn Dahlbäck, Robin P F Dullaart

15 Citationer (Scopus)

Abstract

Plasma apolipoprotein M (apoM) is potentially anti-atherogenic, and has been found to be associated positively with plasma total, LDL and HDL cholesterol in humans. ApoM may, therefore, be intricately related to cholesterol metabolism. Here, we determined whether plasma apoM is affected by statin or fibrate administration in patients with diabetes mellitus.
OriginalsprogEngelsk
TidsskriftAtherosclerosis
Vol/bind213
Udgave nummer1
Sider (fra-til)247-50
Antal sider4
ISSN0021-9150
DOI
StatusUdgivet - 1 nov. 2010

Fingeraftryk

Dyk ned i forskningsemnerne om 'Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus'. Sammen danner de et unikt fingeraftryk.

Citationsformater